CA-MIDEA-GROUP
10.7.2024 10:51:29 CEST | Business Wire | Press release
Midea Group, recognized as a leading global technology and innovation enterprise, has successfully completed its 1H 2024 Campus Recruitment Tour with the final event on July 6th at Stanford University. These recruitment activities also represent a significant step in the company's ongoing pursuit of global expansion and the strategic localization of innovation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240709152530/en/
Midea Group's 2024 1H Overseas Campus Recruitment Tour at Stanford University (Photo: Business Wire)
With a diverse portfolio encompassing smart home solutions, industrial technology, building technology, robotics and automation, and innovative businesses, Midea Group has reaffirmed its dedication to global markets through this comprehensive recruitment initiative. Every year, approximately 15-20% of Midea Group's campus recruits have overseas study backgrounds, significantly enriching the company's international talent pool.
Highlights of the 2024 Midea Campus Recruitment:
- Over 3000 candidates participated in the event
- Over 4 countries and 20 engaging campus offline events conducted
- Over 10 specialized roundtables tailored for doctoral candidates
In-Depth Strategic Sessions:
- Leadership Insights: Keynote sessions led by Midea's CTO, CPO, and other executives provided visionary perspectives on the future of technology and Midea's pivotal role.
- Cultural Deep Dive: Emphasizing Midea's people-centric philosophy, the sessions highlighted the company's commitment to employee wellness, benefits, and personal growth.
- Innovation Showcase: Featuring Midea's expansive R&D network, including the Central Research Institute driving the "2+4+N" global R&D strategy, solidifying Midea's leadership in technological innovation.
Interactive and Immersive Experiences:
- Q&A Sessions: Transparent discussions on Midea's values, opportunities, and expectations.
- Roundtable Discussions: In-depth dialogues on R&D initiatives, career growth, and global presence.
- Alumni Sharing: Personal growth stories from alumni provided firsthand insights into career opportunities within Midea.
A Clear Path to Recruitment:
- Overseas Students Exclusive Channel: Overseas students graduating from January 2024 to December 2025 are all our target candidates and are allowed to submit resumes online.
- Process Clarity: Candidates were guided through a transparent application, interview, and job offer process.
- Diverse Opportunities: Roles spanning R&D, AI, IT, engineering, and more showcased Midea's commitment to diverse skill sets and professional interests.
- Global Outlook: With opportunities in over 40 global cities, Midea offered candidates a chance to work in multicultural environments.
Midea's Ongoing Commitment
From the UK to Germany, Japan, and the United States, Midea's 1H 2024 recruitment journey underscores its steadfast commitment to creating an innovative, inclusive, and open-minded platform. The company continues to invest significantly in its people and R&D, ensuring it remains at the forefront of technological advancement.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240709152530/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
vVARDIS Announces Investment from Apollo—Achieves Unicorn Status27.4.2026 14:51:00 CEST | Press release
Investment will support global commercial expansion of the Curodont™ technology platform, the first and only non-invasive peptide-containing formulations designed to treat tooth decay drill-free throughout the depth of the lesion vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority investment from Apollo-managed funds (“Apollo Funds”). The investment will support vVARDIS’ next phase of global growth and commercial expansion, including the continued rollout of its Curodont™ suite of products. The investment establishes vVARDIS as one of Europe’s few privately owned, billion-dollar-plus, healthcare companies. vVARDIS’ founders and co-CEOs, Drs. Haley and Goly Abivardi, will retain a substantial majority shareholding in the company. vVARDIS is redefining the treatment of cavities through its Curodont™ technology, the first and only commercially available non-invasive peptide-containing formulati
IAS Launches IAS Total TV Solutions Giving Marketers ‘Linear-like’ Transparency for Connected TV27.4.2026 14:30:00 CEST | Press release
‘IAS Total TV’ unlocks show, genre and rating transparency measurement across Disney, NBCUniversal, Paramount and Prime Video, plus multiple opted-in publishers using Publica enabling advertisers to enhance brand suitability while increasing campaign outcomes Integral Ad Science (IAS) today announced ‘IAS Total TV’, a new comprehensive suite of Connected TV (CTV) solutions designed specifically to bring ‘linear-like’ transparency to streaming TV. IAS Total TV can provide marketers with genre, rating, language, show and program-level data in aggregate from Disney, NBCUniversal, Paramount and Prime Video, in addition to multiple opted-in publishers using Publica. IAS Total TV integrates content insights, media quality, supply path and outcomes into a unified view within the IAS Signal user interface (UI). Advertisers can determine when and how they want their advertising to run alongside CTV content, ensuring brand-related and brand suitable environments. “As advertisers continue to doub
Riskified Study Finds Consumers Aren’t Ready to Hand Over Control as AI Transforms Shopping, with Over Half Afraid of Online Fraud27.4.2026 14:00:00 CEST | Press release
New Q1 2026 “Agentic Commerce Pulse” survey from Riskified reveals a growing trust gap in agent-driven commerce, as consumers embrace AI across the shopping journey but remain hesitant to hand over control amid concerns over fraud, security, and accountability Riskified (NYSE: RSKD), a global leader in ecommerce fraud and risk intelligence, today released the Q1 2026 edition of its Agentic Commerce Pulse, a quarterly research series tracking agentic commerce risks and consumer engagement. Following Riskified’s inaugural Q4 2025 survey, which first highlighted the rapid emergence of agent-driven commerce, the latest findings reveal a more complex reality: while AI adoption remains strong, consumer trust is not keeping pace. A widening gap is emerging between how shoppers use AI and how much control they are willing to give it. The survey, conducted among consumers across the United States and the United Kingdom, shows that AI is now firmly embedded in product discovery and decision-maki
Nine in 10 Expect Cross-Border M&A Surge, But 71% of Dealmakers Have Already Changed Course on Deals27.4.2026 14:00:00 CEST | Press release
90% of dealmakers expect cross-border M&A activity to increase over the next 12–24 months75% cite foreign direct investment screening as the biggest threat to deal completion88% report longer signing-to-close timelines than three years ago Cross-border M&A is set for a strong resurgence, with nine in 10 senior dealmakers expecting activity to increase over the next 12 to 24 months, according to new research from CSC, the leading provider of business administration and compliance solutions. However, despite this renewed momentum, execution risk is rising, with regulatory scrutiny and operational challenges making it harder to get deals over the line. CSC¹ surveyed 200 director level and above global dealmakers across private equity, corporate, legal, and advisory roles who have worked on cross-border transactions in the past two years. The report, The New Reality of Cross-Border M&A: More Deals, More Friction, explores how firms are navigating an increasingly complex global deal environ
Mundipharma announces positive topline results from Phase III ReSPECT trial assessing ▼REZZAYO® (rezafungin) for the prophylaxis of invasive fungal diseases in allogeneic haematopoietic stem cell transplantation patients27.4.2026 13:43:00 CEST | Press release
For Trade and Medical Media Only The study primary endpoint was met, showing non-inferiority vs. standard antimicrobial regimen in fungal-free survival at Day 90 Study showed favourable benefit for toxicity-related discontinuations and drug-drug interactions (DDIs) Rezafungin was well tolerated, with a safety profile comparable to standard antimicrobial regimens (SARs) Mundipharma today announced positive Phase III topline results from the global ReSPECT clinical trial evaluating REZZAYO® (rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in adult patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT). The ReSPECT Phase III trial, one of the largest antifungal, multicentre, randomised, double-blind studies evaluated the efficacy and safety of once weekly rezafungin compared with a SAR for the prophylaxis of IFDs, including infections caused by Candida, Aspergillus, and Pneumocystis, in adults undergoing allogeneic HSCT. Patients undergoing a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom